Accès gratuit
Numéro
Med Sci (Paris)
Volume 24, Numéro 10, Octobre 2008
Page(s) 841 - 846
Section M/S revues
DOI https://doi.org/10.1051/medsci/20082410841
Publié en ligne 15 octobre 2008
  1. Junquero D, Rival Y. Syndrome métabolique : quelle définition pour quel(s) traitement(s) ? Med Sci (Paris) 2005; 21 : 1045–53. [Google Scholar]
  2. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party ? Hepatology 1998; 27 : 1463–6. [Google Scholar]
  3. Mendez-Sanchez N, Arrese M, Zamora-Valdes D, Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 2007; 27 : 423–33. [Google Scholar]
  4. Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 2003; 29 : 478–85. [Google Scholar]
  5. Nakamuta M, Kohjima M, Morizono S, et al. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 2005; 16 : 631–5. [Google Scholar]
  6. Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115 : 1343–51. [Google Scholar]
  7. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008; 118 : 829–38. [Google Scholar]
  8. Foufelle F, Hegarty B, Bobard A, et al. Un nouveau rôle de l’insuline dans la régulation du métabolisme glucido-lipidique hépatique. Med Sci (Paris) 2005; 21 : 569–71. [Google Scholar]
  9. Shimano H, Horton JD, Shimomura I, et al. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 1997; 99 : 846–54. [Google Scholar]
  10. Bécard D, Hainault I, Azzout-Marniche D, et al. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 2001; 50 : 2425–30. [Google Scholar]
  11. Liang G, Yang J, Horton JD, et al. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 2002; 277 : 9520–8. [Google Scholar]
  12. Decaux JF, Antoine B, Kahn A. Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem 1989; 264 : 11584–90. [Google Scholar]
  13. Stoeckman AK, Towle HC. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J Biol Chem 2002; 277 : 27029–35. [Google Scholar]
  14. Yamashita H, Takenoshita M, Sakurai M, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 2001; 98 : 9116–21. [Google Scholar]
  15. Cairo F, Rotundo R, Frazzingaro G, et al. Diabetes mellitus as a risk factor for periodontitis. Minerva Stomatol 2001; 50 : 321–30. [Google Scholar]
  16. Dentin R, Pegorier JP, Benhamed F, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 2004; 279 : 20314–26. [Google Scholar]
  17. Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci USA 2004; 101 : 15597–602. [Google Scholar]
  18. Ma L, Sham YY, Walters KJ, Towle HC. A critical role for the loop region of the basic helix-loop-helix/leucine zipper protein Mlx in DNA binding and glucose-regulated transcription. Nucleic Acids Res 2007; 35 : 35–44. [Google Scholar]
  19. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci USA 2001; 98 : 13710–5. [Google Scholar]
  20. Dentin R, Benhamed F, Pegorier JP, et al. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 2005; 115 : 2843–54. [Google Scholar]
  21. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci USA 2003; 100 : 5107–12. [Google Scholar]
  22. Denechaud PD, Bossard P, Lobaccaro JM, et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 2008; 118 : 956–64. [Google Scholar]
  23. Iizuka K, Bruick R K, Liang G, et al. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 2004; 101 : 7281–6. [Google Scholar]
  24. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway: a link between adipose tissue mass and central neural networks. Horm Metab Res 1996; 28 : 619–32. [Google Scholar]
  25. Lindstrom P. The physiology of obese-hyperglycemic mice (ob/ob mice). Scientific World J 2007; 7 : 666–85. [Google Scholar]
  26. Dentin R, Benhamed F, Hainault I, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006; 55 : 2159–70. [Google Scholar]
  27. Cohen P, Miyazaki M, Socci ND, et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002; 297 : 240–3. [Google Scholar]
  28. Xu H, Wilcox D, Nguyen P, et al. Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile. Biochem Biophys Res Commun 2006; 349 : 439–48. [Google Scholar]
  29. Nagle CA, An J, Shiota M, et al. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J Biol Chem 2007; 282 : 14807–15. [Google Scholar]
  30. Capeau J. Voies de signalisation de l’insuline : mécanismes affectés dans l’insulino-résistance. Med Sci (Paris) 2003; 19 : 834–9. [Google Scholar]
  31. De Luis O, Valero MC, Jurado LA. WBSCR14, a putative transcription factor gene deleted in Williams-Beuren syndrome: complete characterisation of the human gene and the mouse ortholog. Eur J Hum Genet 2000; 8 : 215–22. [Google Scholar]
  32. Cherniske E M, Carpenter T O, Klaiman C, et al. Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet 2004; 131 : 255–64. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.